Novo Nordisk løftes af FDA-advarsel til 30 kopifirmaer – fortsætter op efter dansk lukketid
4/3 21:13
uddrag fra Zerohedge: Novo Nordisk shares in Copenhagen finally caught a bid after the U.S. Food and Drug Administration issued 30 warning letters to telehealth companies for making false and misleading claims regarding compounded GLP-1 products (otherwise known as copycat GLP-1s) offered on their websites. Citi analyst Geoff Meacham told clients that a quick […]...